{"companyId":272558,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"ダイアンサス セラピューティクス株式会社","headOfficeLocation":"ニューヨーク州ニューヨーク市, アメリカ合衆国","presidentName":"マリノ ガルシア","companySummary":null,"stockCode":"DNTH","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["dianthustx.com"],"businessContents":["重度の自己免疫疾患の治療法を開発している。","臨床段階のモノクローナル抗体および融合タンパク質を開発している。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000169058526000006/dnth-20251231.htm","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}